会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明公开
    • NEUTROPHILIA INHIBITOR
    • NEUTROPHILIE,缝边
    • EP1698339A4
    • 2009-06-17
    • EP04807556
    • 2004-12-22
    • NISSAN CHEMICAL IND LTDTAISHO PHARMA CO LTD
    • IWAMA TAKEHISATSURUZOE NOBUTOMO
    • A61K31/501A61P7/00A61P11/00C07D401/12
    • C07D401/12A61K31/501
    • A neutrophilia inhibitor effective in treatments for the incidence or progress of acute infectious diseases, collagen disease, chronic obstructive pulmonary disease (COPD), chronic bronchitis, pulmonary emphysema, small airway diseases, gout, Cushing syndrome, myelofibrosis, tumorous neutrophilia, polycythemia vera, and pathological states observed in, e.g., steroid agent administration. The neutrophilia inhibitor contains a 3(2H)-pyridazinone compound represented by the formula (I) or a pharmacologically acceptable salt thereof. [In the formula, R1, R2, and R3 each independently represents hydrogen or C1-6 alkyl; X represents halogeno, cyano, or hydrogen; Y represents halogeno, trifluoromethyl, or hydrogen; and A represents optionally hydroxylated C1-8 alkylene.]
    • 对急性传染病,胶原病,慢性阻塞性肺病(COPD),慢性支气管炎,肺气肿,小气道疾病,痛风,库欣综合征,骨髓纤维化,肿瘤性中性粒细胞增多症,真性红细胞增多症, 和在例如类固醇剂给药中观察到的病理状态。 嗜中性粒细胞增多抑制剂含有由式(I)表示的3(2H) - 哒嗪酮化合物或其药理学上可接受的盐。 [式中,R 1,R 2和R 3各自独立地表示氢或C 1-6烷基; X代表卤代,氰基或氢; Y代表卤代,三氟甲基或氢; A代表任选羟基化的C1-8亚烷基。]